Catalyst Wire Dossier Catalyst Wire Dossier

Buprenorphine Transdermal Patch, Second Generation

buprenorphine · Mundipharma Research Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Buprenorphine Transdermal Patch, Second Generation, covering 2014-09-30 to 2014-09-30. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Proportionality and Bioavailability Assessment of Buprenorphine Transdermal Delivery System Second Generation Patches [Phase 1]

See pricing